-
Q1 EPS Forecast for CRISPR Therapeutics Increased by Analyst
Source: Buzz FX / 26 Feb 2025 06:56:19 America/New_York
Q1 EPS Forecast for CRISPR Therapeutics Increased by Analyst Written by MarketBeat February 26, 2025 Share Link copied to clipboard. MaxCyte: Building the Future of Cell and Gene Therapy Innovation CRISPR Therapeutics AG ( NASDAQ:CRSP - Fre
Read more...